m6A Target Gene Information
General Information of the m6A Target Gene (ID: M6ATAR00554)
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
Fak
can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Browse Drug
Wilms tumor 1-associating protein (WTAP) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by WTAP | ||
Cell Line | mouse embryonic stem cells | Mus musculus |
Treatment: WTAP-/- ESCs
Control: Wild type ESCs
|
GSE145309 | |
Regulation |
|
logFC: 5.98E-01 p-value: 1.29E-24 |
More Results | Click to View More RNA-seq Results |
In total 1 item(s) under this regulator | ||||
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene | [1] | |||
Response Summary | WTAP could promote migration/invasion and suppress chemo-sensitivity to gemcitabine in PC. Further mechanical investigation revealed that WTAP could bind to and stabilize Focal adhesion kinase 1 (Fak) mRNA which in turn activated the Fak-PI3K-AKT and Fak-Src-GRB2-Erk1/2 signaling pathways. | |||
Target Regulation | Up regulation | |||
Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | ||
Responsed Drug | Gemcitabine | Approved | ||
Pathway Response | PI3K-Akt signaling pathway | hsa04151 | ||
Cell Process | RNA stability | |||
In-vitro Model | T3M-4 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_4056 |
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0428 | |
hTERT-HPNE | Normal | Homo sapiens | CVCL_C466 | |
HPDE6c7 | Normal | Homo sapiens | CVCL_0P38 | |
BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0152 | |
In-vivo Model | Twenty-four female BALB/c athymic nude mice, which were 4-6 weeks old and weighed 20.0-25.0 g, were obtained from the Animal Research Center of PUMCH. WTAP-OE, WTAP-NC, shWTAP and shNC-lentivirus infected MIA PaCa-2 cells (5 × 106) were suspended in 50 uL PBS and then injected subcapsularly into the pancreatic tissue by 1-mL syringes. | |||
Pancreatic cancer [ICD-11: 2C10]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the m6A-centered Disease Response | [1] | |||
Response Summary | WTAP could promote migration/invasion and suppress chemo-sensitivity to gemcitabine in PC. Further mechanical investigation revealed that WTAP could bind to and stabilize Focal adhesion kinase 1 (Fak) mRNA which in turn activated the Fak-PI3K-AKT and Fak-Src-GRB2-Erk1/2 signaling pathways. | |||
Responsed Disease | Pancreatic cancer [ICD-11: 2C10] | |||
Target Regulator | Wilms tumor 1-associating protein (WTAP) | WRITER | ||
Target Regulation | Up regulation | |||
Responsed Drug | Gemcitabine | Approved | ||
Pathway Response | PI3K-Akt signaling pathway | hsa04151 | ||
Cell Process | RNA stability | |||
In-vitro Model | T3M-4 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_4056 |
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0428 | |
hTERT-HPNE | Normal | Homo sapiens | CVCL_C466 | |
HPDE6c7 | Normal | Homo sapiens | CVCL_0P38 | |
BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0152 | |
In-vivo Model | Twenty-four female BALB/c athymic nude mice, which were 4-6 weeks old and weighed 20.0-25.0 g, were obtained from the Animal Research Center of PUMCH. WTAP-OE, WTAP-NC, shWTAP and shNC-lentivirus infected MIA PaCa-2 cells (5 × 106) were suspended in 50 uL PBS and then injected subcapsularly into the pancreatic tissue by 1-mL syringes. | |||
Gemcitabine
[Approved]
In total 1 item(s) under this drug | ||||
Experiment 1 Reporting the m6A-centered Drug Response | [1] | |||
Response Summary | WTAP could promote migration/invasion and suppress chemo-sensitivity to gemcitabine in PC. Further mechanical investigation revealed that WTAP could bind to and stabilize Focal adhesion kinase 1 (Fak) mRNA which in turn activated the Fak-PI3K-AKT and Fak-Src-GRB2-Erk1/2 signaling pathways. | |||
Target Regulator | Wilms tumor 1-associating protein (WTAP) | WRITER | ||
Target Regulation | Up regulation | |||
Responsed Disease | Pancreatic cancer | ICD-11: 2C10 | ||
Pathway Response | PI3K-Akt signaling pathway | hsa04151 | ||
Cell Process | RNA stability | |||
In-vitro Model | T3M-4 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_4056 |
PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0480 | |
MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0428 | |
hTERT-HPNE | Normal | Homo sapiens | CVCL_C466 | |
HPDE6c7 | Normal | Homo sapiens | CVCL_0P38 | |
BxPC-3 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0186 | |
AsPC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens | CVCL_0152 | |
In-vivo Model | Twenty-four female BALB/c athymic nude mice, which were 4-6 weeks old and weighed 20.0-25.0 g, were obtained from the Animal Research Center of PUMCH. WTAP-OE, WTAP-NC, shWTAP and shNC-lentivirus infected MIA PaCa-2 cells (5 × 106) were suspended in 50 uL PBS and then injected subcapsularly into the pancreatic tissue by 1-mL syringes. | |||